A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic ...

US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava ...

SYNT-101 introduces an innovative method for weight loss by temporarily redirecting nutrient absorption in the small ...

Most current drugs for obesity and diabetes, like liraglutide, target a hormone receptor known as GLP-1. These medications ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

GLP-1 receptor agonists may modestly reduce the risk for 14 obesity-related cancers, especially colorectal cancer, among ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

A new obesity management service allowing people to access lifestyle support as well as obesity medication if appropriate ...